PapersFlow Research Brief
Whipple's Disease and Interleukins
Research Guide
What is Whipple's Disease and Interleukins?
Whipple's Disease and Interleukins refers to research exploring the role of interleukins, particularly interleukin-16, in the pathogenesis, immune response, and treatment of Whipple's disease caused by the bacterium Tropheryma whipplei.
Whipple's disease involves chronic infection by Tropheryma whipplei, with studies addressing bacterial cultivation, genome sequencing, PCR diagnosis, and antibiotic susceptibility. Interleukin-16 is implicated in the disease's immune dysregulation. The field encompasses 8,928 papers focused on central nervous system manifestations, immunosuppressive therapy associations, and immune reconstitution inflammatory syndrome.
Topic Hierarchy
Research Sub-Topics
Tropheryma whipplei Pathogenesis
This sub-topic examines the molecular mechanisms of Tropheryma whipplei infection, host-pathogen interactions, and disease progression in Whipple's disease. Researchers investigate bacterial virulence factors and immune evasion strategies.
Interleukin-16 in Whipple's Disease
This sub-topic explores the role of IL-16 in the immunopathology of Whipple's disease, including its association with T-cell responses. Studies link IL-16 dysregulation to clinical manifestations.
PCR Diagnosis of Whipple's Disease
This sub-topic develops and validates PCR-based diagnostic methods for detecting Tropheryma whipplei in tissues and fluids. Research focuses on sensitivity, specificity, and clinical utility.
Antibiotic Susceptibility of Tropheryma whipplei
This sub-topic assesses microbial susceptibility patterns of T. whipplei to antibiotics, including cultivation challenges and resistance profiles. Studies guide optimal treatment regimens.
Central Nervous System Involvement in Whipple's Disease
This sub-topic investigates neurological manifestations, diagnosis, and management of CNS Whipple's disease. Researchers study imaging, CSF analysis, and prognosis.
Why It Matters
Understanding interleukins in Whipple's disease aids diagnosis via PCR and management of complications like central nervous system involvement and immune reconstitution inflammatory syndrome. Genetic biomarkers for susceptibility linked to immunosuppressive therapy guide patient screening in clinical settings. Microbial susceptibility data supports targeted antibiotic treatments, reducing chronic multi-organ impacts observed in pathology studies.
Reading Guide
Where to Start
"The Orphan Nuclear Receptor RORγt Directs the Differentiation Program of Proinflammatory IL-17+ T Helper Cells" by Ivanov et al. (2006), as it provides foundational insights into IL-17 pathways relevant to interleukin dysregulation in infections like Whipple's disease.
Key Papers Explained
Ivanov et al. (2006) "The Orphan Nuclear Receptor RORγt Directs the Differentiation Program of Proinflammatory IL-17+ T Helper Cells" establishes RORγt's role in IL-17+ T cell differentiation, which Park et al. (2005) "A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17" builds on by defining CD4 T cell lineages producing IL-17. Mangan et al. (2006) "Transforming growth factor-β induces development of the TH17 lineage" extends this by showing TGF-β's influence on Th17 development. Zhou et al. (2007) "IL-6 programs TH-17 cell differentiation by promoting sequential engagement of the IL-21 and IL-23 pathways" connects IL-6 to Th17 via IL-21/IL-23, linking to Hunter and Jones (2015) "IL-6 as a keystone cytokine in health and disease" on IL-6's broad inflammatory roles.
Paper Timeline
Most-cited paper highlighted in red. Papers ordered chronologically.
Advanced Directions
Current research emphasizes interleukin-16's specific interactions with Tropheryma whipplei, PCR refinements for atypical presentations, and genetic susceptibility markers. Frontiers include modeling immune reconstitution inflammatory syndrome and optimizing antibiotic protocols based on susceptibility profiles.
Papers at a Glance
| # | Paper | Year | Venue | Citations | Open Access |
|---|---|---|---|---|---|
| 1 | The Orphan Nuclear Receptor RORγt Directs the Differentiation ... | 2006 | Cell | 5.0K | ✓ |
| 2 | Functional Bowel Disorders | 2006 | Gastroenterology | 4.7K | ✕ |
| 3 | A distinct lineage of CD4 T cells regulates tissue inflammatio... | 2005 | Nature Immunology | 4.2K | ✓ |
| 4 | Transforming growth factor-β induces development of the TH17 l... | 2006 | Nature | 3.0K | ✕ |
| 5 | IL-6 as a keystone cytokine in health and disease | 2015 | Nature Immunology | 2.4K | ✕ |
| 6 | Interleukin-17 Family Members and Inflammation | 2004 | Immunity | 2.3K | ✓ |
| 7 | IL-6 programs TH-17 cell differentiation by promoting sequenti... | 2007 | Nature Immunology | 2.1K | ✕ |
| 8 | Classification of Inflammatory Bowel Disease | 1989 | Scandinavian Journal o... | 2.0K | ✕ |
| 9 | Interleukin-23 Promotes a Distinct CD4 T Cell Activation State... | 2003 | Journal of Biological ... | 1.8K | ✓ |
| 10 | IL-17 Family Cytokines and the Expanding Diversity of Effector... | 2007 | Annual Review of Immun... | 1.8K | ✕ |
Latest Developments
Recent research indicates that Whipple's disease involves complex immune mechanisms, including immune reconstitution inflammatory syndrome (IRIS) characterized by cytokine responses such as TNF-α and IFN-γ, and elevated levels of IL-16 and apoptosis markers (Frontiers in Immunology, 2023; PLoS ONE, 2007). Additionally, studies have shown that tumor necrosis factor inhibitors can exacerbate Whipple's disease by reprogramming macrophages and inducing apoptosis (Frontiers in Immunology, 2021). Regarding interleukins, increased circulating IL-16 levels are associated with disease activity, highlighting ongoing research into cytokine involvement in disease progression (PLoS ONE, 2007).
Sources
Frequently Asked Questions
What causes Whipple's disease?
Whipple's disease is caused by infection with the bacterium Tropheryma whipplei. Research covers its cultivation and genome sequencing for better understanding. PCR diagnosis confirms cases accurately.
How does interleukin-16 relate to Whipple's disease?
Interleukin-16 is involved in the immune response during Whipple's disease pathogenesis. It contributes to the dysregulation seen in Tropheryma whipplei infections. Studies highlight its role alongside other interleukins in disease progression.
What are common diagnostic methods for Whipple's disease?
PCR diagnosis detects Tropheryma whipplei DNA in tissues. It enables early identification, especially for central nervous system manifestations. This method improves outcomes over traditional histopathology.
Why is Whipple's disease associated with immunosuppressive therapy?
Immunosuppressive therapy increases susceptibility to Whipple's disease by impairing immune control of Tropheryma whipplei. Research identifies potential genetic biomarkers for at-risk patients. This informs clinical monitoring in treated populations.
What is immune reconstitution inflammatory syndrome in Whipple's disease?
Immune reconstitution inflammatory syndrome occurs post-treatment as immunity recovers against persistent Tropheryma whipplei antigens. It manifests with exacerbated inflammation. Management requires balancing antibiotics and anti-inflammatory measures.
How is antibiotic susceptibility tested in Whipple's disease?
Microbial susceptibility to antibiotics is assessed for Tropheryma whipplei isolates. Studies determine effective regimens against the bacterium. This guides prolonged therapy to eradicate infection.
Open Research Questions
- ? How does interleukin-16 specifically modulate T cell responses to Tropheryma whipplei in Whipple's disease?
- ? What genetic biomarkers predict susceptibility to Whipple's disease under immunosuppressive therapy?
- ? Why do some Tropheryma whipplei infections progress to central nervous system involvement?
- ? How can bacterial cultivation challenges for Tropheryma whipplei be overcome for routine diagnostics?
- ? What triggers immune reconstitution inflammatory syndrome during antibiotic treatment of Whipple's disease?
Recent Trends
The field maintains 8,928 works on Whipple's disease and interleukins, with sustained focus on Tropheryma whipplei genome sequencing and interleukin-16 immune roles.
No growth rate data available over 5 years.
Keyword trends highlight PCR diagnosis and immunosuppressive associations persisting without recent preprints or news.
Research Whipple's Disease and Interleukins with AI
PapersFlow provides specialized AI tools for Medicine researchers. Here are the most relevant for this topic:
Systematic Review
AI-powered evidence synthesis with documented search strategies
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Find Disagreement
Discover conflicting findings and counter-evidence
Paper Summarizer
Get structured summaries of any paper in seconds
See how researchers in Health & Medicine use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching Whipple's Disease and Interleukins with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Medicine researchers